Working... Menu

Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy (DPN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03219320
Recruitment Status : Completed
First Posted : July 17, 2017
Last Update Posted : January 18, 2019
Syneos Health
Information provided by (Responsible Party):

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : November 2, 2018
  Actual Study Completion Date : November 2, 2018